BUD November 21st Options Begin Trading

A covered call strategy on Anheuser-Busch InBev (BUD) stock, utilizing a $60.00 strike call with a 20-cent premium against shares trading at $58.91, offers a potential 2.19% return by November 21st if the stock is called away. There is a 53% chance the call expires worthless, yielding a 0.34% return (1.93% annualized "YieldBoost") from the premium, though this strategy caps upside potential. Implied and historical volatilities are both noted at 27%.

Analysis

The analysis presents a specific income-generating options strategy for Anheuser-Busch InBev (BUD) through a covered call. By selling a November 21st expiration call option with a $60.00 strike price against shares purchased at $58.91, an investor collects a $0.20 premium. This transaction structure limits the maximum potential return to 2.19% if BUD's stock price is at or above $60.00 at expiration, at which point the shares would be called away. A key data point is the 53% probability that the option will expire worthless, allowing the investor to retain the shares and the 0.34% premium yield (or 1.93% annualized). Critically, the option's implied volatility of 27% is identical to the stock's trailing twelve-month historical volatility. This alignment suggests the option is not priced with an unusual premium for future uncertainty, indicating the market's expectation for BUD's price movement is in line with its recent past.

Key Decisions for Investors

• This covered call strategy is suitable for investors holding BUD who have a neutral to modestly bullish short-term outlook and prioritize generating incremental income over capturing significant upside potential beyond the $60.00 strike price.
• Investors should weigh the capped maximum return of 2.19% against the opportunity cost of forfeiting all share price appreciation above $60.00, a key risk if the stock were to rally unexpectedly.
• The parity between the option's implied volatility and the stock's historical volatility at 27% suggests the premium is fairly priced relative to recent risk, offering no clear edge from selling unusually inflated or depressed volatility.